Alumis Inc. reported $7.4M of revenue over the trailing twelve months. 8 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $7.4M (to Q2 2026). Net income: −$439M, trailing twelve months to Q2 2026. Free cash flow: −$352M, trailing twelve months to Q2 2026. Operating margin: −6297%, trailing twelve months to Q2 2026.

ALMSAlumis Inc.

Healthcare

$7.17+72% 1Y

$7.17

$3.9552 weeks$30.07

ALMS as reported

Alumis Inc. reported $7.4M of revenue over the trailing twelve months. 8 reported series are charted on this page, each one as filed.

$7.4M

Revenue, trailing twelve months · to Q2 2026 · every figure below is as filed, with no scoring applied

Net income: −$439M
Net income · +93% year on year · trailing twelve months to Q2 2026
Free cash flow: −$352M
Free cash flow · +1.4% year on year · trailing twelve months to Q2 2026
Operating margin: −6297%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ALMS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$7.4M	n/a	Q2 2026
Net income	−$439M	+93%	Q2 2026
EPS	−$3.85	+28%	Q2 2026
Operating margin	−6297%	n/a	Q2 2026
Net margin	−6020%	n/a	Q2 2026
ROE	−71%	n/a	Q2 2026
ROA	−56%	n/a	Q2 2026
Free cash flow	−$352M	+1.4%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.